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Subha V Raman1*, Ashish Aneja2 and Wael N Jarjour3Abstract
Vasculitis, the inflammation of blood vessels, can produce devastating complications such as blindness, renal failure,
aortic rupture and heart failure through a variety of end-organ effects. Noninvasive imaging with cardiovascular
magnetic resonance (CMR) has contributed to improved and earlier diagnosis. CMR may also be used in serial
evaluation of such patients as a marker of treatment response and as an indicator of subsequent complications.
Unique strengths of CMR favoring its use in such conditions are its abilities to noninvasively visualize both lumen
and vessel wall with high resolution. This case-based review focuses on the large- and medium-vessel vasculitides
where MR angiography has the greatest utility. Because of increasing recognition of cardiac involvement in
small-vessel vasculitides, this review also presents evidence supporting greater consideration of CMR to detect and
quantify myocardial microvascular disease. CMR’s complementary role amidst traditional clinical, serological and
other diagnostic techniques in personalized care for patients with vasculitis is emphasized. Specifically, the CMR
laboratory can address questions related to extent and severity of vascular involvement. As ongoing basic and
translational studies better elucidate poorly-defined underlying molecular mechanisms, this review concludes with a
discussion of potential directions for the development of more targeted imaging approaches.
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Vasculitis, the inflammation of blood vessels, is rare
[1,2], yet those affected may suffer high rates of morbid-
ity and mortality. A significant contributor to poor out-
comes is delay in diagnosis. While advances in serologic
testing have afforded somewhat earlier diagnosis, there
remains a need for better techniques to detect vasculitis
and improve outcomes. Advances in non-invasive im-
aging are poised to fill this gap, particularly in vasculitis
involving large- and medium-sized arteries where these
studies can play a significant role in i) establishing the
correct diagnosis, ii) determining disease extent and ac-
tivity and iii) measuring treatment response [3].
Recognition that not only vascular but also cardiac se-
quelae occur in certain vasculitides makes cardiovascular
magnetic resonance (CMR) appealing amidst the various
imaging options available [4]. Some clinicians may not
consider CMR due to concerns surrounding the use of
gadolinium-based contrast in vasculitis patients who fre-
quently present with significant renal dysfunction. The* Correspondence: raman.1@osu.edu
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reproduction in any medium, provided the oravailability of excellent non-contrast MR angiography
techniques can allay such concerns, allowing CMR in
high-risk patients who may have the most to benefit
from timely use of the technology.
The paucity of well-defined pathogenic mechanisms
for many of these disorders renders in some respect in-
adequate each of the many vasculitis classification
schemes. In this review, we use the common approach
that focuses on the sizes of the involved blood vessel
that can guide CMR protocols and afford differential
diagnosis of imaging findings. This approach, however,
requires an appreciation that while specific types of vas-
culitis classically affect certain-sized blood vessels, there
remains a spectrum of involvement across the various
levels of the vasculature. What follows is a brief sum-
mary of the techniques most relevant to the CMR vascu-
litis examination followed by case-based illustrations of
the major primary inflammatory vasculitides.
While this review focuses on the primary vasculitides,
secondary vasculitis and mimics of vasculitis warrant
consideration when evaluating a patient with suspected
vasculitis [5]. Secondary vasculitis may occur in the set-
ting of infection, malignancy, connective tissue disease
[6], drugs and environmental exposure. AnotherLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sels is primary central nervous system (CNS) angiitis or
involvement of the CNS with a systemic vasculitis. This,
too, is beyond the scope of this review but can be pur-
sued in greater depth in several recent publications of
MR’s role in the diagnosis and serial assessment of cere-
bral vasculitis [7,8].
CMR techniques in the vasculitis examination
The evaluation of vasculitis by CMR may include angi-
ography, vessel wall imaging and occasionally myocardial
assessment (Figure 1, Table 1). The typical patient pre-
senting with a vasculitis query to the CMR laboratory is
one whose clinical, serological and even histopatho-
logical evaluations may have already led to diagnosis of a
particular condition. For instance, a patient who initially
presented with classic signs and symptoms of giant cell
arteritis (GCA), underwent definitive temporal artery bi-
opsy and received prednisone therapy, may subsequently
be referred for CMR to define the extent of aortic in-
volvement. Less commonly, the CMR laboratory is the
first to propose vasculitis as a mechanism underlying the
observed findings (Figure 2).
Techniques for angiography include both contrast-
enhanced MR angiography (CE-MRA) as well as non-
contrast approaches, both recently summarized in this
journal by Hartung et al [9]. MRA’s sensitivity is typic-
ally at or near 100% while specificity tends to be lower,
underscoring the potential to overestimate degree of
stenosis particularly in branch vessels of the aorta. TheFigure 1 CMR provides a variety of techniques for noninvasive, three
useful in patients with known or suspected vasculitis such as contras
angiography (B and C, with lines indicating planes of reformatting of data
(D, shown in inverted grayscale).workhorse technique for demonstration of luminal sten-
osis remains CE-MRA, with improved spatial resolution,
better vessel-to-background contrast and reduced vol-
ume requirement for exogenous contrast material with
higher field strength. These advantages offset limitations
imposed by radiofrequency field inhomogeneity that
increases with field strength. Technical developments in
coil hardware and parallel acquisition techniques make
higher field scanners appealing platforms for CE-MRA.
Non-contrast approaches for angiography abound,
starting with traditional time-of-flight (TOF) angiog-
raphy. While infrequently relied upon for stenosis as-
sessment in extracranial arteries, TOF angiography does
provide complementary information to CE-MRA. Rapid,
lower-resolution 3D TOF imaging prescribed over a
large volume helps identify sites of disease for higher-
resolution 2D dark blood scans for vessel wall imaging.
Our laboratory and many others have found 3D naviga-
tor SSFP imaging to be tremendously useful for non-
contrast bright blood MRA of the thoracic aorta [10],
particularly when CE-MRA may not be feasible due to
contraindications to gadolinium-based contrast adminis-
tration. Similarly, 3D non-contrast dark blood MRA may
be useful in certain settings, particularly when higher
heart rate, greater field strength or other approaches
help shorten what are typically longer scan times [11].
Dark blood imaging is also preferable when susceptibility
artifact obscures interpretation of bright blood images.
Another SSFP-based non-contrast approach that is par-
ticularly appealing for lower extremity imaging is non--dimensional imaging of the entire vascular tree that may be
t-enhanced bright blood angiography. (A), noncontrast dark blood
from the 3D acquisition) and noncontrast bright blood angiography




Dark blood stacks typically in axial,
coronal and sagittal planes e.g.
HASTE
Provides vessel wall imaging as well








Appropriate vasculature should be
covered depending on clinical
questions and known or suspected
diagnosis (see Table 2)
POSTCONTRAST
T1-weighted vessel wall imaging
e.g. VIBE or FAME
Additional vessel wall imaging,
particularly useful to delineate
thickening and thrombus
CARDIAC ACQUISITIONS
Multiplane cine imaging e.g. SSFP
Aortic valve velocity-encoded cine
Myocardial imaging: T2 precontrast,
T1W early post contrast, late
post-gadolinium imaging
May be appropriate when aortic
root disease involves the aortic
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(Figure 1) [12]. While initially developed for atheroscler-
osis imaging of the peripheral arteries, it warrants con-
sideration in vasculitides where peripheral vascular
involvement is not uncommon. Some of the more com-
monly used elements of the CMR vasculitis protocol are
listed in Table 1. Table 2 suggests which segments of the
arterial tree should be imaged in the most common pri-
mary vasculitides. Table 3 summarizes studies compar-
ing magnetic resonance to other modalities commonly
used to evaluate the inflammatory vasculitidies.
Large vessel vasculitis
Giant cell arteritis (GCA)
GCA is a granulomatous, large-vessel vasculitis with a pre-
dilection for individuals aged ≥70 years. Up to 60% of
patients with GCA have findings consistent with polymyal-
gia rheumatica such as proximal muscle morning stiffness
and aching [13]. The overall incidence is highest in indivi-
duals of Scandinavian descent, where it occurs in 18 to 20
per 100,000 individuals [14]. GCA can be diagnosed as
present if 3 of the following 5 classical findings are
observed: i) age ≥50 years; ii) new-onset or new type of
localized pain in the head; iii) temporal artery tenderness;
iv) erythrocyte sedimentation rate ≥50 mm/h; and v) arter-
ial biopsy specimen showing vasculitis [15]. However, ap-
preciating that non-classic symptoms may be the initial
manifestation of GCA, high clinical suspicion and rapid in-
stitution of, for instance, steroid therapy is needed to avoiddreaded complications such as vision loss. Examination of
the retina with fluorescein angiography holds particular
value in diagnosis [16].
Classically, GCA affects the extracranial branches of the
carotid artery, notably the temporal artery. Risk of develop-
ing thoracic and abdominal aortic aneurysms is 17 and 2
times higher, respectively, in patients with GCA compared
to age-matched individuals without GCA [17]. Aortic in-
volvement in GCA carries a very high risk of rupture and
death, with an average survival of 1 year in GCA patients
with thoracic aortic dissection [18]. This considerable in-
crease in mortality due to aortic involvement mandates a
low threshold for aortic imaging in this disease [19,20].
Subclavian artery and axillary artery involvement are not
uncommon in GCA, and MR performs well in delineating
such [21]. GCA affected lower extremities alone in 17% of
patients in a recent series [22]. Recognition of long stenotic
segments and vessel wall thickening with MR can prompt
specific treatment (e.g., prednisone) in such GCA patients
who may present solely with claudication. Follow-up MR
may identify reduced vessel wall thickening indicating a fa-
vorable response to therapy [4].
The sensitivity and specificity of Doppler ultrasonog-
raphy (US) compared to the clinical diagnosis of tem-
poral arteritis in a meta-analysis of 23 studies was 69
and 82% respectively [23]. Additionally, since US assess-
ment was confined to detection of the “halo” sign in the
temporal artery, it cannot reliably assess the thoracic
aorta, whose involvement can lead to the serious and
fatal complications as discussed above. Nonetheless,
European League Against Rheumatism (EULAR) guide-
lines assign US a class Ia recommendation for the diag-
nosis of GCA vs. IIa for MRA [24]. Alternatively, 3T
MRI of the cranial arteries has a high sensitivity and spe-
cificity in detecting vessel wall inflammation when com-
pared with temporal artery biopsy (89-94%, and 92-100%
respectively), albeit in small studies [25,26]. Positron
emission tomography (PET) may have a higher sensitiv-
ity than MRI in detecting GCA according to some retro-
spective studies [27,28]. However, PET is limited in its
ability to demonstrate temporal artery inflammation be-
cause of inadequate spatial resolution and inability to
distinguish luminal changes in close proximity to
glucose-avid brain tissue. In addition, it involves consid-
erable exposure to ionizing radiation. Recently, high
resolution dynamic contrast-enhanced (DCE) MRI per-
formed well in detecting vessel inflammation in patients
with suspected arteritis [29]. The abnormal extraction
fraction computed from first-pass MR imaging, implying
increased endothelial leakiness, correlated well with
FDG-uptake in arterial walls by PET-CT.
Current data suggest no clear role for either CMR or
PET in GCA patient follow up. PET does detect decline
in activity with treatment, but in most cases the uptake
Figure 2 Vasculitis was identified in a 28 year-old female with unrelenting back pain initially referred for MR examination to rule out
aortic dissection; additional history revealed recent unintentional 5 kg weight loss. A. Contrast-enhanced magnetic resonance angiography
(CE-MRA) showed diffuse luminal irregularities (arrows). B. Pre-contrast dark blood imaging indicated marked aortic wall thickening to 9–10 mm
(arrowheads). There was marked elevation of inflammatory markers including erythrocyte sedimentation rate (ESR, 94 mm/hr) and c-reactive
protein (7.3 mg/L) levels. Symptoms markedly improved with prednisone, with reduced ESR (12 mm/hr) and aortic wall thickness at 12-month
follow-up.
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The most common conditions prompting referral for MR examination are shown with X indicating typically-involved segments of the extracranial arterial tree. This
scope warrants consideration when prescribing the imaging protocol. Note that atypical manifestations have been reported in virtually all vessel territories for
these disorders.
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Table 3 MRI in inflammatory vasculitidies
Author (Reference #) Year
published




2011 Retrospective MRA in patients vs.
retrospective normal
controls
28 MRA detected GCA in 67% with good inter-observer
agreement
Bley [25] 2005 Prospective MRA vs. Biopsy 20 16/17 GCA + by biopsy were MRA +, all 3 GCA – were
MRA -
Bley [26] 2005 Unclear MRA in diagnosed GCA
patients
21 MRA demonstrated vascular involvement in all previously
diagnosed 9 patients
Walter [27] 2005 Unclear PET in GCA 30 patients and 31
controls
PET had a sensitivity of 73.3% and specificity of 83.9%
Meller [28] 2005 Unclear PET vs. MRA 15 FUO patients MRA and PET had comparable sensitivity and specificity
for detecting inflammation. Identical vascular territories
were identified in the majority but disparate territories in
a large minority
Cyran [29] 2011 Prospective PET vs. MRI 17 Both Dynamic Contrast Enhanced MRI and PET had
identical sensitivity and specificity (86 and 90%
respectively) in assessing carotid and vertebral
inflammation
Both [31] 2008 Prospective PET vs. MRI 25 MRI and PET found unreliable for assessing large-vessel
inflammation in GCA patients on pre-existing
immunosuppressive therapy
Takayasu’s Arteritis
Li [37] 2011 Retrospective Whole body MRI 42 Wall thickness and post-contrast intensity by MRI higher
in active group than remissive group (6.12 vs. 4.31 mm
and 1.56 vs. 1.17)





7 All patients had increased wall thickness and 5 had
enhancement with contrast (4 had clinically active
disease)
Choe [39] 2000 Prospective MRI 26 patients and 16
controls
MR imaging was concordant with clinical findings in 23
patients (88.5%), with laboratory findings in most patients
(ESR in 92.3% [24/26] and CRP in 84.6% [22/26])
Jiang [40] 2012 Prospective MRA 26 patients-16
classified as active
and 10 as inactive
Active group had more stenosis in left SCA than the
inactive group (14/16, 87.5% vs. 2/10, 20%; p<0.01)
greater vessel wall thickness in left CCA (11/16, 68.75%
vs. 1/10, 10%; p<0.01) and left SCA (9/16, 56.25% vs. 0/10,
0%; p<0.01)
Tso [41] 2002 Retrospective MRA 24 MRA revealed vessel wall edema in 94% (17 of 18), 81%
(13 of 16), and 56% (24 of 43) of studies during periods
of unequivocally active disease, uncertain disease activity,
and apparent clinical remission, respectively. ESR and CRP




2000 Prospective MRA vs. CA 30 Takayasu arteritis was diagnosed in 20 patients - MRA
accurately revealed 323 (98%) of 330 arteries, but 7 (2%)
stenotic lesions were overestimated as occluded. The
sensitivity and specificity of MRA for diagnosis of
Takayasu arteritis were 100%. PA lesions were
demonstrated in 10 (50%) of the 20 patients.
Garg [35] 2011 Prospective MRA vs. DSA 22 Diagnosis confirmed by MRA in all patients. MRA with
sensitivity, specificity, PPV, NPV and DA for detection of a
>50% lesion was 98.33%, 97.25%, 92.18%, 99.43% and
97.52% respectively.
Kawasaki Disease
Greil [54] 2007 Prospective MRA vs. CA 6 Complete agreement between MRA and CA in detection
of coronary aneurysms (n=15).Excellent agreement for
aneurysm diameter, length, and distance from the
ostium.
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Table 3 MRI in inflammatory vasculitidies (Continued)
Tacke [55] 2011 Prospective MRA vs.
Echocardiography
63 MRA detected coronary aneurysms in 15 patients,
whereas echo detected aneurysms in 11.
Greil [56] 2002 Prospective MRA vs. CA 6 Excellent agreement for assessment of coronary
aneurysm maximal diameter and length
Mavrogeni
[57]
2004 Prospective MRA vs. CA 13 6 patients had coronary aneurysms and 7 had ectasia.
MRA and CA agreed completely for the diagnosis of
aneurysms
Suzuki [58] 2006 Retrospective MRA vs. CA 106 MRA agreed well with CA for detecting aneurysms and
stenoses
Arnold [59] 2007 Prospective MRA vs. Multidetector CT
vs. CA
16 100% agreement between MDCT and CA in the
detection of aneurysms and stenoses. MRI and CA had




2011 Unclear MRA in Kawasaki disease
patients in convalescence
13 MRA revealed high prevalence of coronary ectasia and
myocarditis in 46% (n=13) of convalescing Kawasaki
disease patients
Abbreviations. MRA: magnetic resonance angiography, PET: positron emission tomography, MRI: Magnetic resonance imaging, ESR: erythrocyte sedimentation rate,
CRP: C-reactive protein, SCA: subclavian artery, CCA: common carotid artery, CA: conventional angiography, PPV: positive predictive value, NPV: negative predictive
value, DA: diagnostic accuracy.
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changes associated with vessel wall remodeling. In one
GCA study including patients with a complicated
course, PET findings correlated poorly with clinical and
laboratory criteria of disease activity and MRI findings.
In the same study, PET could not predict disease relapse
[30]. Of note, MRI with dark blood imaging may demon-
strate wall thickening and edema that persists despite
clinical and laboratory improvements [31].Takayasu arteritis (TA)
TA shares many of the vascular findings of GCA but
occurs in considerably younger patients, classically
women more often than men under the age of 50 years.
Diagnosis requires angiographic abnormalities [32] plus
one of the following four findings: i) decreased periph-
eral artery pulse(s) and/or claudication of extremities; ii)
blood pressure difference >10 mm Hg between extrem-
ities; iii) bruits over aorta and/or its major branches; or
iv) hypertension. The mandate for angiographic evidence
of disease makes MR an important component of the
TA evaluation, especially in children where invasive
angiography and CT hold considerably less appeal.
TA, previously termed “pulseless disease” because bi-
lateral subclavian artery occlusion eliminates the radial
pulse (Figure 3), can also affect the aorta, pulmonary ar-
teries and renal arteries; some data suggest a predilec-
tion for bilateral vessel involvement [33]. In a direct
comparison of MRI with invasive angiography, Yamada
et al. demonstrated accurate evaluation of 98% vascular
territories and also demonstrated pulmonary artery in-
volvement in 50% of patients, identical to the distribu-
tion delineated by conventional angiography [34].
Similarly, Garg et al. have also shown a high correlationbetween MRA and digital subtraction angiography in
detecting stenosis and aneurysm formation [35].
Using MR’s ability to assess vessel wall thickening and
disease activity, Andrews et al. underscored the utility of
MR over traditional x-ray angiography in facilitating
early diagnosis and guiding treatment [36]. Given the ex-
tent of potential arterial involvement and the require-
ment for accurate diagnosis (Figures 3, 4, 5), complete
aortic imaging with visualization of all major branches
should be performed in every TA patient [13]. Li and
colleagues demonstrated the diagnostic utility in patients
with confirmed TA of whole-body MRA combined with
dark blood axial plane vessel wall imaging from neck to
pelvis [37]. A correlation with disease activity (clinical
and laboratory) with inflammation on MRI was demon-
strated by Desai et al., Choe et al., and Jiang et al. using
primarily pre-contrast T1W and T2W dark blood im-
aging but also post-gadolinium T1W imaging [38-40],
but not replicated by Tso et al., who with T2W-STIR
demonstrated evidence of inflammation by MRI when
the disease was clinically quiescent [41]. With histo-
logical evidence of ongoing inflammation in Takayasu
patients when the disease is clinically quiescent [42],
imaging-based detection of vessel wall inflammation
warrants further evaluation in clinical trials that examine
the effect of treating subclinical disease on outcomes.
Idiopathic aortitis
This inflammatory, noninfectious aortitis has been
described both as an isolated aortic disease at one end a
spectrum that includes GCA-TA at the other end [43].
However, unlike GCA and TA, idiopathic aortitis infre-
quently presents with constitutional symptoms but more
likely manifests as aortic aneurysm in the setting of
asthma or eczema [44]. With recognition that tissue-
Figure 3 A 42 year-old female presented with bilateral arm fatigue, worse with lifting above the head. Physical examination showing
absent radial pulses, and serum inflammatory markers including erythrocyte sedimentation rate and c-reactive protein levels were elevated.
Anemia was also present (hematocrit 30%). With a presumptive diagnosis of Takayasu arteritis, treatment with prednisone was initiated and
CE-MRA was requested. A. Volume rendering shows patency of the common brachiocephalic trunk (C); the proximal portion of the left subclavian
artery (L SC, arrow) is patent while distally it is occluded (open arrow). B. Maximum intensity projection (MIP) shows reconstitution of the distal L
SC (arrows) via collaterals. C. Similarly, a MIP image shows that the right subclavian artery is occluded (open arrow) and fills distally (filled arrows)
via collaterals. D. Volume rendering demonstrates high-grade stenosis (arrow) of the left vertebral artery (V).
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qua non of this disease [45], it has been more appropri-
ately included in the spectrum of IgG4-mediated disor-
ders [46]. Typical manifestations include aneurysms of
the ascending thoracic or abdominal aorta (Figure 6),
and two large studies reported a prevalence of 4 to 6%
when examining surgical aortic specimens [47,48]. When
histology is available, the diagnosis can be made by dem-
onstration of an abundance of plasma cells spanning the
intima, media and adventitia and by their positive stain-
ing for IgG4 (Figures 7, 8). An association with retro-
peritoneal fibrosis has also been described that may lead
to ureteral obstruction. CMR in a patient with idiopathic
aortitis should span the thorax and abdomen, withFigure 4 Images of the thoracic aorta in a patient with Takayasu arte
mild dilatation of the descending aorta that measured 33 mm at the level
wall thickening can be appreciated using techniques such as non-contrast
4–5 mm of the thoracic aorta wall, arrows). Additional post-contrast T1-wei
technique (C, same location as B) further confirm vessel wall thickening inattention paid not only to aortic dimensions and wall




This leading cause of acquired heart disease in children
begins with fever persisting for at least four days. Add-
itionally, diagnosis requires 4 of the following 5 fea-
tures: i) desquamative rash of the extremities or
perineal area; ii) polymorphous exanthema; iii) bilateral
conjunctival injection; iv) injection of oral and
pharyngeal mucosa; and v) cervical lymphadenopathy
[32,49]. Involvement of the coronary arteries producesritis are shown. A. CE-MRA in the sagittal plane demonstrates diffuse,
indicated by arrows vs. 25 mm more proximally (arrowheads). Vessel
inversion recovery dark blood imaging (B, showing thickening of
ghted imaging such as the volumetric interpolated breathhold
this patient.
Figure 5 Images of the abdominal aorta in a patient with Takayasu arteritis are shown. A. Volume rendering viewed in the
antero-posterior direction of a CE-MRA acquired using a coronal slab demonstrates marked irregularity of the infraceliac abdominal aorta.
B. Maximum intensity projection of a CE-MRA obtained using a sagittal slab at a subsequent visit shows ostial disease of the celiac trunk (arrow)
and absence of the superior mesenteric artery (SMA, open triangle). C. Post-contrast volumetric interpolated breathhold T1-weighted image
shows thickening of the wall of the abdominal aorta (arrow) and obliteration of the SMA ostium (notched arrow).
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infarction and heart failure. Coronary artery aneurysms
develop in up to 25% of untreated children [50]; intra-
venous immunoglobulin therapy reduces this incidence
to 3 or 4% [51].Figure 6 A 58 year-old male with fatigue and palpitations underwent
aortic root. CMR was ordered to assess the aorta. A. MIP of the CE-MRA sh
6 cm in diameter compared to the 2.5 cm arch. B. Single heartbeat true FIS
also evident on HASTE dark blood imaging in the axial (C) and sagittal planAs cardiovascular death has been reported up to 18
years after the initial illness [52], both pediatric and
adult cardiovascular specialists should be attuned to the
essential elements of follow-up evaluation. The initial
evaluation of the child with acute KD includestransthoracic echocardiography that indicated dilatation of the
ows marked dilatation of the ascending aorta, which measured up to
P bright blood image shows thickening of the aortic wall (arrowhead),
es (D).
Figure 7 A. Histopathological examination of the aortic wall in a patient with idiopathic aortitis demonstrates an abundance of plasma
cells in the intima. B. Low power light microscopy demonstrates inflammatory cells in media (right side) and adventitia (left side). Warthin-Starry
stain was negative for spirochetes. Images courtesy of Drs. Mark Brownell and Anne Albers.
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particularly feasible at high volume centers and in smal-
ler children who receive sedation [53]. Because the pres-
ence and extent of coronary artery involvement dictate
follow-up treatment and testing [49], poor visualization
by echo should prompt consideration of CMR for coron-
ary artery imaging in KD [54]. CMR’s lack of ionizing ra-
diation and noninvasive nature make it preferable in
children and young adults with KD over modalities such
as computed tomography and invasive x-ray angiography
(Figures 9, 10). Tacke et al. recently demonstrated
the utility of a more comprehensive assessment
afforded by CMR that included rest and stress perfu-
sion imaging, cine imaging for wall motion abnor-
mality and late post-gadolinium imaging for infarct
scar [55]. Greil et al. first demonstrated equivalence
of MRI with conventional angiography in detecting
coronary aneurysms, stenosis and complete occlusions
using a free-breathing, T2-prepared, 3D bright-blood se-
quence with navigator gating and tracking [56]. Subse-
quently, Mavrogeni et al. confirmed complete agreement
between conventional angiography and this MRA tech-
nique in demonstrating coronary ectasia and aneurysms
[57]. Using bright-blood and dark-blood imaging, Suzuki
et al. replicated the equivalence of MRI with conventionalFigure 8 A. Inflammatory infiltrate in a patient with idiopathic aortiti
B. Immunohistochemistry demonstrates IgG4-positive plasma cells. Imagesangiography and superiority over echocardiography in
detecting aneurysms and stenosis in patients ranging from
4 months to 37 years [58].
Arnold et al. compared conventional angiography,
multi-detector CT (MDCT) and MRI in 16 patients and
showed 100% concordance between conventional angi-
ography and MDCT, and 93% concordance between
MRI and coronary angiography for aneurysm detection
[59]. MRI missed one stenotic lesion, while providing
additional information regarding myocardial inflamma-
tion and injury. Kan et al. recently summarized the
safety and accuracy of contemporary CT with ultra-low
radiation exposure for pediatric patients [60], including
5 with suspected coronary involvement in KD with non-
diagnostic CMR examination. More recently, using free-
breathing, T2-prepared, 3D-SSFP, whole heart approach
with navigator gating and tracking, Greil et al. demon-
strated complete and excellent agreement between MRA
and coronary angiography [54].
Mavrogeni et al. reported comprehensive CMR findings
using both coronary and myocardial evaluation in 13 KD
patients thought to be in convalescence (stage II and III,
20–25 days after disease onset) [61]. Of the six patients
with demonstrable myocardial inflammation by T2W
STIR (which had resolved in all 6 by repeat CMR 3s is seen to extend from the adventitia into the mediastinal fat.
courtesy of Drs. Mark Brownell and Anne Albers.
Figure 9 An 11 year-old boy presented to a pediatric hospital with chest and jaw pain while playing one year after a prolonged febrile
illness. Initially, CT angiography was performed (A, image courtesy of Dr. Christopher Learn) that showed thrombus in a calcified aneurysm of
the left anterior descending coronary artery (LAD, arrow). In the setting of elevation of the serum troponin and possible need for coronary
intervention, the patient was transferred to a nearby adult hospital. Invasive angiography (B) showed thrombus nearly occluding LAD that was
treated with angioplasty and stent placement. C. Coronary MRA performed in another patient with KD using a navigator-triggered slab prescribed
perpendicular to the aortic root demonstrates a 9 mm proximal LAD aneurysm (arrow). LV = left ventricle Ao = aorta.
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yet all had lower LV ejection fraction by cine imaging.
Additional 3D ECG-gated steady state free precession
navigator-gated non-contrast coronary MRA identified
coronary aneurysms and intracoronary thrombus, some of
which were missed by echocardiography. In joint guide-
lines issued by the American Academy of Pediatrics and
the American Heart Association in 2004, echocardiog-
raphy, MRI, and conventional coronary angiography were
all accorded level of evidence C for detection of coronary
abnormalities due to lack of prospective data [62].
Polyarteritis nodosa (PAN)
Whereas KD is considered an acute medium vessel vascu-
litis, PAN is typically a subacute disorder affecting adults
more than children. While all the vasculitides are rela-
tively rare, higher incidences of PAN have been reported
in Alaskan and Kuwaiti natives [1]. PAN classically affects
visceral arteries such as renal, hepatic and mesenteric ar-
teries. Presenting findings often include hypertension,
fever, musculoskeletal symptoms, abdominal angina and
neuropathy, occasionally with hepatitis B antigen or DNA
in the serum [63].Figure 10 LGE-CMR in three-chamber (left), mid short-axis (center) an
in a boy with Kawasaki disease.While invasive x-ray angiography may traditionally be
used to demonstrate renal artery involvement in PAN,
especially when therapy via coil embolization is being
considered (Figure 11), CMR may uncover both coron-
ary involvement and its sequelae. Mavrogeni and collea-
gues identified coronary artery aneurysms in 4 of 16
PAN patients using 3D whole heart navigator MRA [64],
and resultant myocardial injury was demonstrated in a
patient with PAN by Kobayashi et al. using T2-weighted
and LGE imaging of the myocardium [65]. In a longi-
tudinal study of patients with immune-mediated dis-
ease comparing incident coronary heart disease (CHD)
hospitalization to the entire population of Sweden,
Zöller et al. found in 248 patients with PAN a standar-
dized incidence ratio for CHD of 3.81 (95% CI 2.72–5.19)
in the first year after PAN hospitalization [66]. Prospective
studies are needed to better define the utility of CMR in
earlier detection and targeted intervention to prevent CHD
complications in PAN.
Behçet disease (BD)
This disorder is notorious for involving both arteries and
veins across vessel sizes, and typically affects young malesd vertical long axis (right) planes show LAD-territory infarct scar
Figure 11 Traditional x-ray angiography may still be employed in most centers to diagnose polyarteritis nodosa involving the visceral
arteries, such as the focal, segmental aneurysms (left panel, up to 4.5 cm in diameter) of the hepatic artery seen in this 77 year-old
woman with acute abdominal pain, syncope and bleeding within the liver parenchyma by CT. The angiographic appearance was
consistent with PAN. Coil embolization (right panel) was performed with resolution of bleeding. Images courtesy Dr. Leslie Cooper.
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with recurrent venous thrombi in a young male with aph-
thous ulcers and/or uveitis should raise one’s suspicion of
BD (Figure 12). Of note, vascular involvement may pre-
cede the more classical findings [67].
Pulmonary artery aneurysms contribute to excess mortal-
ity via rupture; aggressive treatment with steroids, immuno-
suppression and occasionally surgery has reduced mortality
[68]. Recognizing such, vascular imaging of the patient with
BD should at some point include the pulmonary arteries. A
recent study identified cardiac complications in 6% of
patients with this disease including pericarditis, right ven-
tricular thrombus, myocardial infarction and endomyocar-
dial fibrosis [69] – all of which can be readily demonstrated
with a suitably-prescribed CMR examination.
Small vessel vasculitis: Churg-Strauss syndrome (CSS)
Patients with small vessel vasculitis have significant con-
stitutional symptoms. Other more specific complaintsFigure 12 A 25 year-old Middle Eastern male with a 6 year history of
anticoagulation presented to a vascular medicine specialist. Physical e
aspect of the calf (A, Courtesy Dr. Steven Dean) and oral ulcerations. B. Sub
occlusion of a previously placed filter in the inferior vena cava (arrowhead)
contrast volumetric interpolated breathhold T1-weighted image shows signare related to the particular bed that is affected. For ex-
ample, palpable purpura is the hallmark dermatological
manifestation of small vessel vasculitis, whereas alveolar
hemorrhage may occur if the lung parenchyma is
involved. Clinical clues to the diagnosis of CSS may in-
clude asthma, hypereosinophilia and fever, and half of
these patients test positive for anti-neutrophilic cytoplas-
mic antibody(ANCA) [3]. CSS warrants particular atten-
tion in this review given that rates of cardiac
involvement have been reported to be as high as 75 to
90%. Cardiovascular involvement in CSS consists of
pericarditis, myocarditis, cardiomyopathies and intraca-
vitary thrombi [70,71].In a series of 11 patients undergo-
ing CMR, various forms of myocardial injury was
detected in all patients. Mean LVEF was 45% with im-
pairment of LV function in 6 patients, edema in 4, peri-
cardial effusion in 7, and LGE-positivity in 9 including
some with normal LV size and EF [72]. The subendocar-
dial pattern of myocardial involvement in CSS can berecurrent deep venous thrombi despite therapeutic
xamination demonstrated painful erythematous lesions over the lateral
sequent contrast-enhanced magnetic resonance venogram showed
. Extensive venous collaterals are evident. C. Coronal plane post-
al void delineating the IVC filter (arrows).
Figure 13 A 37-year-old female with biopsy-proven Churg-Strauss-vasculitis was referred for CMR examination The left ventricle was
slightly enlarged with mild systolic dysfunction: LV ejection fraction was 45%. Late post-gadolinium myocardial enhancement images in
various planes show septal intramural and anteroseptal and anterior subendocardial lesions. Images courtesy Drs. Ralf Waβmuth and Jeanette
Schulz-Menger.
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[73,74]. Existing data support the use of LGE and T2 myo-
cardial imaging in defining the presence and extent of car-
diac disease (Figure 13) [70,72]. Future studies using
perfusion CMR may help elucidate to what extent micro-
vascular disease contributes to myocardial involvement.
Review and Conclusions
Su and colleagues, in one of the few studies of molecular
imaging specifically targeting non-atherosclerotic vascular
inflammation, showed feasibility of targeting the enzyme
myeloperoxidase that is a marker of certain vasculitides
[75]. Ongoing advances in understanding the molecular
bases for these varied conditions may translate into novel
diagnostic imaging approaches. Remarkably, diagnosis still
heavily relies on direct tissue examination; development of
MR agents that target IgG4 or ANCA could hopefully im-
prove the diagnostic specificity of noninvasive imaging
and reduce the need for histopathology.
In conclusion, diagnosis and serial assessment of
patients with inflammatory vasculitis require clinical, la-
boratory and imaging assessments. The CMR laboratory
in particular offers a spectrum of techniques for nonin-
vasive angiography and vessel wall imaging, both with
and without need for exogenous contrast administration.
The utility of these techniques in patients with inflam-
matory vasculitis is realized only through 1) their timely
use at initial presentation for accurate delineation of
both presence and extent of disease and 2) an ongoing
dialog among CMR specialists and the clinicians charged
with initial diagnosis and long-term management. Such
efforts coupled with continued advances in molecular
understanding and treatment warrant further investiga-
tion given the considerable morbidity and mortality for
patients with primary vasculitis.
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